1. All of the plaintiff's claims are dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. Facts of recognition;

A. On November 7, 2014, the Plaintiff (BB) concluded a Type 1 insurance contract indicated in the separate sheet (hereinafter “instant No. 1 insurance contract”) with the Defendant as the beneficiary and the insured as the beneficiary, and entered into a secondary insurance contract indicated in the separate sheet (hereinafter “instant No. 2 insurance contract”) with the Defendant as the beneficiary and the insured on May 29, 2015.

B. On November 12, 2015, the Defendant received either an influoral fluoral fluoral fluoral fluoral and an artificial insemination influoral mology from the right eye on November 12, 2015. On November 19, 2015, the Defendant received either an influoral fluoral fluoral or artificial insemination influoral (hereinafter “influoral fluoral fluoral fluoral fluoralsium”). On November 24, 2015, the Defendant received insurance proceeds from the Plaintiff totaling KRW 9,493,254 (= KRW 1 insurance contract of this case KRW 5,80,00, KRW 2 insurance contract of this case KRW 3,693,254).

C. Meanwhile, the current status of insurance contracts concluded by August 2017, including each of the instant insurance contracts, with the Defendant as the insured by August 2017 is as follows.

Serial No. 1 T. 41 T. 40 G. 147 G. 7147 G. 7147 G. 7147 G. 7147 G. 1747, 2011, Samsung Life Insurance Co., Ltd. 27, 201 at the first T. 3DB Life Insurance Co., Ltd.’s 1309 effective 4DB Life Insurance Co., Ltd.’s 407 effective 1407. 5, Korea Family Health Insurance Co., Ltd.’s 1407 effective 5, 1407, NEW 1404 (F/500,000) normal 6K Life Insurance Co. 147, 2014